Global Unfractionated Heparin Market Size, Share, Forecast Report, 2020-2027

The global Unfractionated Heparin market garnered revenue around USD 1.2 Billion in 2019 and projected to reach USD 1.6 Billion in 2027, with at a compound annual growth rate (CAGR) 6.5% throughout the estimate period from 2020 to 2027.

Unfractionated heparin is a naturally occurring anticoagulant that is primarily in dialysis and heart lung machines to prevent blood clots as well as for the treatment of blood clotting disorder like deep venous thrombosis and pulmonary embolism. Due to its immediate onset of action, short half-life, simple laboratory monitoring, ability to get reversed (protamine), and low cost have led to its wide adoption. Increase in use of unfractionated heparin for the treatment of venous thromboembolism (VTE) includes deep vein thrombosis (DVT) and pulmonary embolism (PE) along with increasing number of surgical procedures are the major drivers for global unfractionated heparin market.

Patent expiration for majority of unfractionated heparin have already created a huge latent opportunity for generic and biosimilars manufacturers in the forthcoming years.

This research report encompasses precise assessment of the market with the help of comprehensive qualitative insights and supportable prognoses regarding market size, consumption and production. The projections presented in the report have been derived using proven research methodologies and assumptions. It does so by means of comprehensive qualitative insights, historical statistics, and verifiable predictions about market revenue and sales.

The rapidly budding threat owed to the eruption of COVID-19 is impacting lives, communities, businesses, and industries across the globe. With businesses shuttered, flights grounded, COVID-19 is about to affect the global economy in different ways such as by directly upsetting production and demand, by generating supply chain disruption, and by its financial impact on firms and financial markets. Therefore, this report covers COVID-19 outbreak impact analysis on the Unfractionated Heparin market under the research study. The market estimates offered in the report are the outcome of in-depth extensive secondary research, primary interviews and in-house professional assessments. These market evaluations have been measured by reviewing the impact of numerous social, political and economic factors coupled with recent market dynamics affecting the Unfractionated Heparin market growth.

The global Unfractionated Heparin market is characterized by the presence of numerous small as well as medium scale companies. These players are largely focused towards forward integration via raw material production, product manufacturing, and distribution across various industry verticals. The report recognizes numerous crucial manufacturers of the market. This research study aids to comprehend the strategies and associations that companies are converging to survive in this competitive marketplace. This report assists in understanding footprints of the manufacturers with the help of their global revenue, production, capacity and average selling price analysis for period 2016-2027.

Major manufacturers analysed under this study comprises:

  • Becton
  • Dickinson and Company
  • bioMérieux S.A.
  • Bio-Rad Laboratories, Inc
  • Eiken Chemical Co, Ltd.
  • EMD (Merck) Millipore
  • Hi-Media Laboratories Pvt. Ltd.
  • Neogen Corporation
  • Sigma-Aldrich Co. LLC
  • Scharlab S.L.
  • Thermo Fisher Scientific,

This report delivers market breakdown and its revenue, consumption, production analysis and projections by categorizing it depending on parameters such as type, application/end-user, and region. This research report delivers the analysis and prognosis of revenue, production, price, market share and growth trend for different products such as:

The global Unfractionated Heparin Market has been segmented as follows:

Global Unfractionated Heparin Market, by Source

  • Bovine   
  • Porcine

Global Unfractionated Market, by Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Regional Analysis and Forecast

Further, this research study analyses market size, production, consumption and its advancement trends at global, regional, and country level for period 2016 to 2027 and covers following region in its scope:

  • North America
    • United States
    • Canada
  • Europe
    • Germany
    • United Kingdom
    • Italy
    • France
    • Rest of EU
  • Asia Pacific
    • China
    • India
    • Japan
    • Southeast Asia
    • Rest of APAC
  • Central & South America
    • Brazil
    • Argentina
    • Rest of Central & South America
  • Middle East and Africa
    • UAE
    • Saudi Arabia
    • Rest of MEA